Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

NCT00171418 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis